Doctor Liang Xie

Nanjing Maternity and Child Health Care Hospital, Nanjing (China)

Membership: ESC Professional Member

Follow

Contributor content

Targeting the HIF-1/ASC pathway with dapagliflozin protects against sleep apnea-exacerbated myocardial damage in heart failure

Presentation

Targeting the HIF-1/ASC pathway with dapagliflozin protects against sleep apnea-exacerbated myocardial damage in heart failure

ESC 365 is supported by

novartis

Explore sponsored resources